Connections: Reflections from the Frontlines of the COVID Pandemic - Episode 2
This activity has been archived and credit is no longer available.
In the early months of 2020, a new respiratory viral infection appeared in China. The virus, SARS-COV-2 (for severe acute respiratory syndrome coronavirus 2) would lead to a global pandemic in producing COVID-19 disease. Little was known about the disease, its spread, its many manifestations, treatments, and the long-term complications of infections. Globally experts across public health, epidemiology, genetics and genomics, virology, vaccine development, drug development, clinical research, clinical medicine, supply chains, transportation, telecommunications, and telemedicine, and more, responded rapidly as the pandemic spread and the challenges in management became increasingly complex. New variants arose and continue to arise. As we move to the close of the first two years of the experience, there are reasons for hope as vaccines and therapeutic agents have become available and been deployed. Much has been learned and has been and continues to be captured in the literature about the clinical approaches to care. However, within and across our organizations, institutions, hospitals, and clinics, there is a rich experience of innovation, sacrifice, dedication, resilience, and individual heroism within our professionals who served on the frontlines across the pandemic and that can inform our planning for the future across many domains ranging from education and training, care coordination, logistics, team building, psychosocial support, and more. We have structured these as reflective, one-on-one conversations with colleagues from an array of professions and disciplines to share their narratives and reflect on what was lost, what was found, and what was discovered over the last 24 months. There is much to be captured and learned before these memories diminish over time.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
In the early months of 2020, a new respiratory viral infection appeared in China. The virus, SARS-COV-2 (for severe acute respiratory syndrome coronavirus 2) would lead to a global pandemic in producing COVID-19 disease. Little was known about the disease, its spread, its many manifestations, treatments, and the long-term complications of infections. Globally experts across public health, epidemiology, genetics and genomics, virology, vaccine development, drug development, clinical research, clinical medicine, supply chains, transportation, telecommunications, and telemedicine, and more, responded rapidly as the pandemic spread and the challenges in management became increasingly complex. New variants arose and continue to arise. As we move to the close of the first two years of the experience, there are reasons for hope as vaccines and therapeutic agents have become available and been deployed. Much has been learned and has been and continues to be captured in the literature about the clinical approaches to care. However, within and across our organizations, institutions, hospitals, and clinics, there is a rich experience of innovation, sacrifice, dedication, resilience, and individual heroism within our professionals who served on the frontlines across the pandemic and that can inform our planning for the future across many domains ranging from education and training, care coordination, logistics, team building, psychosocial support, and more. We have structured these as reflective, one-on-one conversations with colleagues from an array of professions and disciplines to share their narratives and reflect on what was lost, what was found, and what was discovered over the last 24 months. There is much to be captured and learned before these memories diminish over time.
Educational Objectives
At the conclusion of the conference, participants should be able to:
- Describe one or more themes that warrant consideration for planning purposes for improvements in the future.
- Reflect on gaps that may have been revealed in current practice by an identified theme.
- Identify what steps that you might take, if any, over the next 12 months.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Infectious Disease
Interest Groups
- COVID
- Hospital Medicine
- Primary Care
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
-
Lauren Moore, BSN, RN, CCRN
Baylor St. Luke's Medical Center
-
-
Term of Approval
December 1, 2022 through March 31, 2024. Original release date: December 1, 2022
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
Activity Directors
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
-
Abraham Mendoza
IT Project Management Specialist
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Planning Committee Member
-
Michael Fordis, M.D.
Senior Associate Dean and Director, Center for Collaborative and Interactive Technologies (CCIT)
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: